This is the authors' abstract. We don't add key points for this paper.
OBJECTIVE: To compare the preventive effect of daily repeated low-level red light (RLRL) and 0.01% low-dose atropine eye drops (LDA) on myopia. METHODS: This was a 12-month prospective comparative study. 216 Children aged 7-12 years using either RLRL or LDA for myopia prevention were enrolled between July 10, 2024 to August 15, 2024. 192 completed the 12-month follow-up, last case went for clinical visit on August 28, 2025. The primary outcome was the 12-month myopia incidence. Secondary outcomes included changes in the spherical equivalent error (SER) and changes in the axial length (AL). RESULTS: The 12-month myopia incidence was 30.7% (36/117) and 13.3% (10/75) for the LDA and RLRL groups, respectively. The former was significantly higher than the latter (difference, 17.4%, 95% CI: 5.2% to 28.1%; p=0.028). 69 pairs of children were matched from each group using propensity matching score method, where age, gender, baseline SER, and baseline AL were balanced between groups. The 12-month myopia incidence was 29.0% (20/69) and 11.6% (8/69) for the LDA and RLRL groups, respectively. The LDA group was still significantly higher than the RLRL group (difference, 17.4%, 95% CI: 3.9% to 30.3%; p=0.038). The 12-month changes in the SER were 0.08 D and -0.49 D for the RLRL group and the LDA group, respectively, the mean difference was -0.57 (95% CI:-0.73 to -0.41) D, p<0.001. The average changes in AL were 0.02 mm and 0.29 mm for the RLRL group and LDA group, respectively, the mean difference was 0.27 (95% CI: 0.11 to 0.43) mm, p<0.001. 19.7% (23/117) Children in the LDA group reported photophobia, no adverse event was observed in the RLRL group. CONCLUSION AND RELEVANCE: In this 12-month study, daily RLRL demonstrated superior myopia prevention compared to 0.01% LDA. Myopia incidence was significantly lower with RLRL, with a 60% reduced risk. Propensity-matched analysis confirmed RLRL's efficacy, which better stabilized refractive status and axial elongation. No adverse events occurred with RLRL, while 19.7% of LDA users reported photophobia. RLRL emerges as a safer, more effective preventive intervention for childhood myopia.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: